SNPS Investors Have Opportunity to Lead Synopsys, Inc. Securities Fraud Lawsuit with the Schall Law Firm

SNPS Investors Have Opportunity to Lead Synopsys, Inc. Securities Fraud Lawsuit with the Schall Law Firm GlobeNewswire December 29, 2025 LOS ANGELES, Dec. 29, 2025 (GLOBE NEWSWIRE) — The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Synopsys, Inc. (“Synopsys” or “the Company”) (NASDAQ: SNPS) for […]

DEADLINE APPROACHING: Berger Montague Advises Fiserv, Inc. (FISV) (FI) Investors to Inquire About a Securities Fraud Class Action by January 5, 2026

Philadelphia, Pennsylvania–(Newsfile Corp. – December 29, 2025) – National plaintiffs’ law firm Berger Montague PC announces that a class action lawsuit against Fiserv, Inc. (NASDAQ: FISV) (NYSE: FI) (“Fiserv” or the “Company”) has been filed on behalf of investors who purchased Fiserv shares during the period of July 23, 2025 through October 29, 2025 (the

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Telix Pharmaceuticals

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Telix To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Telix between February 21, 2025 and August 28, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh

Morning Market Pulse: Defense-to-Data Bets, Capital Raises, and AI-Powered Platforms Shape the Open

(Other OTC:XERI), DENVER, Dec. 29, 2025 (GLOBE NEWSWIRE) — U.S. equity markets head into the session with a familiar late-cycle mix: capital formation stories, platform expansion in high-growth regions, and strategic deal chatter tied to AI, infrastructure, and healthcare. From an OTC microcap grabbing national airtime to Nasdaq-listed companies securing enterprise AI mandates, today's narrative

WORK Medical Grants East China Exclusive Distribution Rights for AI-Automated Blood Cell Morphology Analyzer, Sets RMB10 Million Sales Target for 2026

(NASDAQ:WOK), Hangzhou, China, Dec. 29, 2025 (GLOBE NEWSWIRE) — WORK Medical Technology Group LTD (Nasdaq: WOK) (“WORK Medical”, the “Company” or “we”), a supplier of medical devices in China, through its subsidiary, Work (Hangzhou) Medical Treatment Equipment Co., Ltd. and its subsidiaries in China, today announced that its subsidiary, Hunan Saitumofei Medical Treatment Technology Co.,

Morning Market Pulse: Defense-to-Data Bets, Capital Raises, and AI-Powered Platforms Shape the Open

Morning Market Pulse: Defense-to-Data Bets, Capital Raises, and AI-Powered Platforms Shape the Open GlobeNewswire December 29, 2025 DENVER, Dec. 29, 2025 (GLOBE NEWSWIRE) — U.S. equity markets head into the session with a familiar late-cycle mix: capital formation stories, platform expansion in high-growth regions, and strategic deal chatter tied to AI, infrastructure, and healthcare. From

WORK Medical Grants East China Exclusive Distribution Rights for AI-Automated Blood Cell Morphology Analyzer, Sets RMB10 Million Sales Target for 2026

WORK Medical Grants East China Exclusive Distribution Rights for AI-Automated Blood Cell Morphology Analyzer, Sets RMB10 Million Sales Target for 2026 GlobeNewswire December 29, 2025 Hangzhou, China, Dec. 29, 2025 (GLOBE NEWSWIRE) — WORK Medical Technology Group LTD (Nasdaq: WOK) (“WORK Medical”, the “Company” or “we”), a supplier of medical devices in China, through its

Canadian Investment Regulatory Organization Trade Resumption – MCI

Trading resumes in: Company: Minnova Corp. TSX-Venture Symbol: MCI All Issues: Yes Resumption (ET): 10:00 AM CIRO can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair and orderly market. CIRO is the national self-regulatory organization which oversees

ReadyWise Encourages Families to Make Preparedness a New Year's Resolution for 2026

Salt Lake City, Utah–(Newsfile Corp. – December 29, 2025) – As 2026 approaches and families across the country set new goals for the year ahead, ReadyWise is encouraging households to make preparedness one of their most important New Year’s resolutions. With unpredictable weather events, natural disasters, and supply disruptions becoming more common, being prepared is

Bravada Announces Non-Brokered Private Placement

Vancouver, British Columbia–(Newsfile Corp. – December 29, 2025) – Bravada Gold Corporation (TSXV: BVA) (FSE: BRTN) (“Bravada” or “Company”) plans to issue up to 25,000,000 units (“Units”) in a non-brokered private placement at a price of $0.04 per Unit for gross proceeds of $1,000,000 (the “Offering”). Each Unit consists of one common share and one share

Scroll to Top